The shift of orthopedic surgeries from hospitals to outpatient centers has accelerated in the last decade and is not likely to slow down soon, so orthopedic companies have to adapt to the demanding outpatient market segment.
“We're focused on the growth and clinical success of ASCs,” Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes, told Medtech Insight
According to the Ambulatory Surgery Center Association, about 6,100 ASCs perform an estimated 30 million procedures across a range of specialties in the US each year. Orthopedic surgery is the largest ASC segment, including over 2,200 centers certified by the Centers for Medicare and Medicaid Services (CMS).
According to J&J, the ASC market as a whole is growing 6% every year and the orthopedics segment is growing nearly 10% annually.
CMS is trying to incentivize the shift of surgeries to outpatient centers, because they consistently cost less than surgeries in hospitals. (Also see "Medtech Companies Must Adjust To Growth Of Outpatient Centers, ZS Consultant Advises" - Medtech Insight, 2 March, 2020
According to J&J, the ASC market as a whole is growing 6% every year and the orthopedics segment is growing nearly 10% annually.
CMS is trying to incentivize the shift of surgeries to outpatient centers, because they consistently cost less than surgeries in hospitals. (Also see "Medtech Companies Must Adjust To Growth Of Outpatient Centers, ZS Consultant Advises" - Medtech Insight, 2 March, 2020
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
